Faculty profile

Maryam Vaseghi-Shanjani

ResearcherMD/PhD ProgramUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Maryam Vaseghi-Shanjani

Researcher

MD/PhD Program

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
10 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

131

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Enzyme-Linked Immunosorbent Assay Flow Cytometry Immunoblotting Inborn Errors Of Immunity Monogenic Allergic Diseases Quantitative Polymerase Chain Reaction Reporter Assays Transcriptome Analysis

Latest papers

Editorial comment on "Italian pediatric experts" consensus statement on diagnosis and management of primary atopic disorders'.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026 · first author
Primary atopic disorders: inborn errors of immunity causing severe allergic disease.
Current opinion in immunology · 2025 · first author
A Germline Heterozygous Dominant Negative IKZF2 Variant Causing Syndromic Primary Immune Regulatory Disorder and ICHAD.
Journal of clinical immunology · 2025

All 13 publications

Latest funding

72th Lindau Nobel Laureate Meeting Travel Award Recipient
CIHR · 2022 · Nominated PI
$5,000

All 1 grants and awards

13 publications.

Editorial comment on "Italian pediatric experts" consensus statement on diagnosis and management of primary atopic disorders'.

Vaseghi-Shanjani M, Eigenmann P, Riggioni C, Turvey SE

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2026First author

DOI: 10.1111/pai.70356 PMID: 42087058

Primary atopic disorders: inborn errors of immunity causing severe allergic disease.

Vaseghi-Shanjani M, Samra S, Yousefi P, Biggs CM, Turvey SE

Current opinion in immunology2025First author

DOI: 10.1016/j.coi.2025.102538 PMID: 40020536

A Germline Heterozygous Dominant Negative IKZF2 Variant Causing Syndromic Primary Immune Regulatory Disorder and ICHAD.

Lu HY, Vaseghi-Shanjani M, Lam AJ, Sharma M, Mohajeri A, Silva LBR, Gillies J, Yang GX, Lin S, Fu MP, Salman A, Rahmanian R, Armstrong L, Halparin J, Yang CL, Chilvers M, Henkelman E, Rehmus W, Morrison D, Setiadi A, Mostafavi S, Kobor MS, Kozak FK, Biggs CM, van Karnebeek C, Hildebrand KJ, Anna Lehman on behalf of the Care4Rare Canada Consortium, Levings MK, Turvey SE

Journal of clinical immunology2025

DOI: 10.1007/s10875-025-01882-2 PMID: 40295428

A multimorphic variant in ThPOK causes an inborn error of immunity with T cell defects and fibrosis

Vaseghi-Shanjani M, Sharma M, Yousefi P, Samra S, Laverty KU, Jolma A, Razavi R, Yang AHW, Albu M, Golding L

Journal of Experimental Medicine (JEM)2025First author

DOI: 10.1084/jem.20241174

Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with non-syndromic hearing loss and guides future research of unsolved cases.

Velde HM, Vaseghi-Shanjani M, Smits JJ, Ramakrishnan G, Oostrik J, Wesdorp M, Astuti G, Yntema HG, Hoefsloot L, Lanting CP, Huynen MA, Lehman A, Turvey SE, DOOFNL Consortium, Pennings RJE, Kremer H

Human genetics2024

DOI: 10.1007/s00439-024-02706-w PMID: 39406892

Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism.

Samra S, Sharma M, Vaseghi-Shanjani M, Del Bel KL, Byres L, Lin S, Dalmann J, Salman A, Mwenifumbo J, Modi BP, Biggs CM, Boelman C, Clarke LA, Lehman A, Turvey SE

HGG advances2024

DOI: 10.1016/j.xhgg.2023.100259 PMID: 38041405

Dominant negative variants in IKZF2 cause ICHAD syndrome, a new disorder characterised by immunodysregulation, craniofacial anomalies, hearing impairment, athelia and developmental delay.

Mohajeri A, Vaseghi-Shanjani M, Rosenfeld JA, Yang GX, Lu H, Sharma M, Lin S, Salman A, Waqas M, Sababi Azamian M, Worley KC, Del Bel KL, Kozak FK, Rahmanian R, Biggs CM, Hildebrand KJ, Lalani SR, Nicholas SK, Scott DA, Mostafavi S, van Karnebeek C, Henkelman E, Halparin J, Yang CL, Armstrong L, Undiagnosed Diseases Network, Care4Rare Canada Consortium, Turvey SE, Lehman A

Journal of medical genetics2023

DOI: 10.1136/jmg-2022-109127 PMID: 37316189

Transcription factor defects in inborn errors of immunity with atopy.

Vaseghi-Shanjani M, Yousefi P, Sharma M, Samra S, Sifuentes E, Turvey SE, Biggs CM

Frontiers in allergy2023First author

DOI: 10.3389/falgy.2023.1237852 PMID: 37727514

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

Sharma M, Leung D, Momenilandi M, Jones LCW, Pacillo L, James AE, Murrell JR, Delafontaine S, Maimaris J, Vaseghi-Shanjani M

Journal of Experimental Medicine (JEM)2023131 citations

DOI: 10.1084/jem.20221755

Atopy as Immune Dysregulation: Offender Genes and Targets.

Vaseghi-Shanjani M, Snow AL, Margolis DJ, Latrous M, Milner JD, Turvey SE, Biggs CM

The journal of allergy and clinical immunology. In practice2022First author

DOI: 10.1016/j.jaip.2022.04.001 PMID: 35680527

Something wrong or missing on this profile? Suggest a correction

Maryam Vaseghi-Shanjani

Research

Latest papers

Latest funding

Editorial comment on "Italian pediatric experts" consensus statement on diagnosis and management of primary atopic disorders'.

Primary atopic disorders: inborn errors of immunity causing severe allergic disease.

A Germline Heterozygous Dominant Negative IKZF2 Variant Causing Syndromic Primary Immune Regulatory Disorder and ICHAD.

A multimorphic variant in ThPOK causes an inborn error of immunity with T cell defects and fibrosis

Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with non-syndromic hearing loss and guides future research of unsolved cases.

Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism.

Dominant negative variants in IKZF2 cause ICHAD syndrome, a new disorder characterised by immunodysregulation, craniofacial anomalies, hearing impairment, athelia and developmental delay.

Transcription factor defects in inborn errors of immunity with atopy.

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

Atopy as Immune Dysregulation: Offender Genes and Targets.

72th Lindau Nobel Laureate Meeting Travel Award Recipient

Frequent collaborators

David Allan

Clara van Karnebeek

Sara Mostafavi

Carmen Riggioni

Rae Brager

Hanan Ahmed